Stockreport

Kopp Family Office Trims $3.5 Million Worth of Viridian Therapeutics Stake -- What Investors Should Know [Yahoo! Finance]

Viridian Therapeutics, Inc.  (VRDN) 
PDF The estimated value of the transaction was $3.5 million, calculated using the stock's average closing price for the quarter. The fund still held a 55,295-share position [Read more]